Bill117th CongressFiled Mar 8, 2022Health
H.R. 6980
To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Mar 8, 2022)
This bill requires the Food and Drug Administration to conduct a pilot program to increase the number of unannounced inspections of foreign drug manufacturing facilities and evaluate the differences between inspections of domestic and foreign facilities.
What just happenedMar 9, 2022
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Hudson, Richard [R-NC-8](R-NC)Sponsor
1 cosponsor1 D
1cosponsors1committees4actions2related bills
- Introduced in HouseMar 8, 2022
- Mar 9, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 8, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 8, 2022IntroReferralIntro-H
Introduced in House
- Mar 8, 2022IntroReferral1000
Introduced in House